HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dirk Mielenz Selected Research

KHS101

8/2021Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dirk Mielenz Research Topics

Disease

4COVID-19
01/2022 - 01/2021
2Infections
01/2022 - 11/2014
2Fibrosis (Cirrhosis)
08/2017 - 02/2015
2Thrombosis (Thrombus)
07/2017 - 01/2014
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2010 - 11/2010
1Weight Loss (Weight Reduction)
01/2022
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Carcinogenesis
08/2021
1Neoplasms (Cancer)
08/2021
1Fatigue
01/2021
1Anhidrotic Ectodermal Dysplasia 1
01/2021
1Alcoholism (Alcohol Abuse)
01/2020
1Synucleinopathies
01/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2017
1Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2017
1Vascular System Injuries
07/2017
1Experimental Arthritis
01/2017
1Tauopathies
01/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016
1Insulin Resistance
03/2013
1Inflammation (Inflammations)
01/2013
1Nephritis
01/2013
1Rheumatoid Arthritis
12/2010
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2010
1Multiple Myeloma
11/2010
1Plasmacytoma
09/2003

Drug/Important Bio-Agent (IBA)

4AntibodiesIBA
01/2022 - 12/2010
3Proteins (Proteins, Gene)FDA Link
08/2021 - 01/2016
2Monoclonal AntibodiesIBA
01/2022 - 01/2022
1Nucleocapsid ProteinsIBA
01/2022
1N 30IBA
01/2022
1EnzymesIBA
01/2022
1Neutralizing AntibodiesIBA
01/2022
1VaccinesIBA
01/2022
1InterferonsIBA
01/2022
1ImmunosorbentsIBA
01/2022
1creatine transporterIBA
08/2021
1KHS101IBA
08/2021
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
08/2021
1Pharmaceutical PreparationsIBA
08/2021
1EctodysplasinsIBA
01/2021
1Blocking AntibodiesIBA
01/2021
1SARS-CoV-2 spike proteinIBA
01/2021
1alpha-SynucleinIBA
01/2019
1Interleukin-1 (Interleukin 1)IBA
12/2017
1indium-bleomycinIBA
08/2017
1Phosphatidylethanolamines (Cephalins)IBA
07/2017
1Phospholipids (Phosphatides)FDA LinkGeneric
07/2017
1ThrombinFDA Link
07/2017
1AcidsIBA
07/2017
1LipidsIBA
07/2017
1Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
07/2017
1CytokinesIBA
01/2017
1Member 1 Group A Nuclear Receptor Subfamily 4IBA
02/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2015
1Immunoglobulin E (IgE)IBA
11/2014
1Hemostatics (Antihemorrhagics)IBA
01/2014
1Glucose (Dextrose)FDA LinkGeneric
03/2013
1Transcription Factors (Transcription Factor)IBA
03/2013
1Protein Isoforms (Isoforms)IBA
01/2013
1antiglomerular basement membrane antibodyIBA
01/2013
1Mitogen-Activated Protein KinasesIBA
01/2013
1glucose-regulated proteinsIBA
12/2010
1CalnexinIBA
12/2010
1Bortezomib (Velcade)FDA Link
11/2010
1Proteasome InhibitorsIBA
11/2010
1Tyrosine (L-Tyrosine)FDA Link
09/2003
1pervanadateIBA
09/2003

Therapy/Procedure

2Therapeutics
01/2022 - 02/2015